Some people who have had negative experiences with the product called Granuflo are considering a lawsuit in order to receive compensation for damages. Granuflo is a powder that uses sodium diacetate as an ingredient. It is used during hemodialysis. There are outpatient facilities that are equipped for this therapy, and the product is widely used in non-Fresenius and Fresenius clinics alike. Dialysis is a treatment for kidney failure that requires the patient to be hooked up to a machine that filters spare water, creatinine, and waste out of their blood. The ph levels of the blood are balanced by using bicarbonate, an alkaline substance, to bring down acid levels. Bicarbonate is created by the body from the ingredients found in Granuflo. Bicarbonate, in large amounts, has been known to result in cardiac arrest or stroke. Not monitoring the bicarbonate levels of a patient’s blood can lead to alkalosis. Alkalosis occurs when the blood becomes too alkaline.

The most common motivation for a Granuflo lawsuit is the belief that patients suffered injuries due to insufficient warnings about the dangers and likelihood of an alkali dosing error during the use of the product. Fresenius Medical Care claims that they responded appropriately, and have done nothing negligent.

A recall was released in March of 2012, but many patients may have suffered damages by that point. Many people who have had family members die shortly after or during a dialysis treatment have filed a Granuflo lawsuit against Fresenius. Usually, it would be impossible to file a lawsuit if a warning had been issued and use of the product continued after that time. In this situation, however, litigation against this drug is valid due to the suspicious circumstances of the recall. It is claimed that the recall was only issued after Fresenius leaked an internal memo which warned their dialysis centers of the potentials of the chemical. Fresenius, as one of the leading dialysis product and equipment suppliers in the nation, has its products used in dialysis centers other than its own. People who were patients in these non-Fresenius centers may have been at risk due to the belated warning they received. Suspicions about whether or not Fresenius only cautioned its own clinics has caused the FDA (Food And Drug Administration) to investigate the actions of the company further. Although Fresenius maintains that they are not responsible for withholding information, they are cooperating fully with the investigation.

Granuflo was not the only Fresenius product that was found to have a relationship with higher bicarbonate levels. Despite coming in a different form, the liquid Naturalyte was also connected to alkali dosing issues that resulted in heart attacks. Desire to file a Granuflo lawsuit may stem from the fact that the danger of heart attack was six times higher for someone that had used this product during dialysis. Warning only some patients about the dangers of the product could be seen as negligent behavior that put people at unnecessary risk. If someone wants to file a Granuflo lawsuit, it is important to hire an experienced attorney that will use their skills to help mete out justice and see that proper compensation is awarded.